The relationship of microalbuminuria with left ventricular functions and silent myocardial ischemia in asymptomatic patients with type 2 diabetes;Tip 2 diyabetli asemptomatik hastalarda mikroalbüminüri ile sol ventrikül fonksiyonlari ve sessiz miyokart iskemisi arasindaki iliski

Turk Kardiyoloji Dernegi Arsivi

Volumn 37, Issue 2, 2009, Pages 91-97

  Yildirimtürk, Özlem ^a   Kiliçgedik, Mehtap ^a   Tuǧcu, Aylin ^a   Aytekin, Vedat ^a   Aytekin, Saide ^a  

^a FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

Author keywords

Albuminuria; Cardiovascular diseases; Coronary disease; Diabetes mellitus; Exercise test; Myocardial ischemia etiology; Type 2 complications

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ALBUMINURIA; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 67549100790     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kaur J, Singh P, Sowers JR. Diabetes and cardiovascular diseases. Am J Ther 2002;9:510-5.
2. Klein R. Hyperglycemia and microvascular and mac-rovascular disease in diabetes. Diabetes Care 1995;18: 258-68.
3. Haffner SM, Lehto S, Rönnemaa T, Pyöraelä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
4. Guglielmi MD, Pierdomenico SD, Salvatore L, Romano F, Tascione E, Pupillo M, et al. Impaired left ventricular diastolic function and vascular postischemic vaso-dilation associated with microalbuminuria in IDDM patients. Diabetes Care 1995;18:353-60.
5. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000;35:898-903.
6. Erdmann E. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int J Cardiol 2006;107:147-53.
7. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-8.
8. Mogensen CE. Microalbuminuria predicts clinical pro-teinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60.
9. Marshall SM, Alberti KG. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989;70:61-71.
10. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vase Biol 1999;19:1992-7.
11. Mykkänen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997;28:1710-6.
12. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995; 38:610-6.
13. Pedrinelli R, Penno G, Dell'Omo G, Bandinelli S, Giorgi D, Di Bello V, et al. Microalbuminuria and tran-scapillary albumin leakage in essential hypertension. Hypertension 1999;34:491-5.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
15. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel üI). JAMA 2001;285:2486-97.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomeru-lar filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
17. Jensen JS. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Dan Med Bull 2000;47:63-78.
18. Mbanya JC, Sobngwi E, Mbanya DS, Ngu KB. Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria. Diabetes Metab 2001;27:378-82.
19. Feigenbaum H, Armstrong WF, Ryan T, editors. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum's echocardiography. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 138-80.
20. Oh JK, Seward JB, Tajik AJ, editors. Assessment of diastolic function and diastolic heart failure. In: The echo manual. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 120-42.
21. Satman I, Yilmaz T, çengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6.
22. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 2006;17:2106-ll.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28 Suppl l:S37-42.
24. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;l 10:32-5.
25. Ar2nlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005;112:969-75.
26. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-8.
27. Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 2003;20:277-82.
28. noguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, et al. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000;47:37-44.
29. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, et al. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1991; 68:729-34.
30. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 1990;301:92-5.
31. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol 1997;79:134-9.
32. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa P. Detection of coronary artery disease in diabetic patients. Diabetologia 1995;38:726-31.
33. Shim CY, Park S, Choi EY, Kang SM, Cha BS, Ha JW, et al. Is albuminuria an indicator of myocardial dysfunction in diabetic patients without overt heart disease? A study with Doppler strain and strain rate imaging. Metabolism 2008;57:448-52.